JWH-015: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|Synthetic cannabinoid}} | |||
{{ | {{DISPLAYTITLE:''JWH-015''}} | ||
}} | |||
[[File:JWH-015.svg|thumb|right|Chemical structure of JWH-015]] | |||
'''''JWH-015''''' is a synthetic [[cannabinoid]] that acts as a selective agonist for the [[cannabinoid receptor]]s. It is part of the [[naphthoylindole]] family of compounds and is known for its potential therapeutic applications as well as its use in scientific research. | |||
JWH-015 is | |||
== Chemical | ==Chemical Properties== | ||
JWH-015 is chemically classified as a naphthoylindole, with the full chemical name ''(2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone''. It has a molecular formula of C24H23NO and a molecular weight of 341.45 g/mol. The compound is characterized by its indole core structure, which is common among many synthetic cannabinoids. | |||
== | ==Pharmacology== | ||
JWH-015 acts as a selective agonist for the [[CB2 receptor]], with a moderate affinity for the [[CB1 receptor]]. This selectivity makes it of interest for research into the [[endocannabinoid system]] and its potential therapeutic applications, particularly in the modulation of immune responses and inflammation. | |||
== | ===Mechanism of Action=== | ||
JWH-015 is | The primary action of JWH-015 is through its interaction with the CB2 receptor, which is predominantly expressed in the [[immune system]]. Activation of this receptor by JWH-015 can lead to anti-inflammatory effects and modulation of immune cell activity. The compound's lower affinity for the CB1 receptor, which is primarily found in the [[central nervous system]], results in fewer psychoactive effects compared to other cannabinoids. | ||
== | ==Potential Applications== | ||
Research into JWH-015 has explored its potential use in treating conditions such as [[chronic pain]], [[inflammation]], and [[autoimmune diseases]]. Its selective action on the CB2 receptor makes it a candidate for therapies that aim to minimize psychoactive side effects while providing therapeutic benefits. | |||
==Legal Status== | |||
The legal status of JWH-015 varies by country. In some jurisdictions, it is classified as a controlled substance due to its structural similarity to other synthetic cannabinoids that have been associated with recreational use and potential abuse. | |||
==Safety and Toxicology== | |||
As with many synthetic cannabinoids, the safety profile of JWH-015 is not fully understood. Studies have indicated that it may have a lower risk of psychoactive effects compared to other cannabinoids, but its long-term effects and potential toxicity remain areas of active research. | |||
==Related Pages== | |||
* [[Cannabinoid receptor]] | * [[Cannabinoid receptor]] | ||
* [[ | * [[Synthetic cannabinoid]] | ||
* [[ | * [[Endocannabinoid system]] | ||
* [[CB1 receptor]] | |||
* [[CB2 receptor]] | |||
[[Category:Synthetic cannabinoids]] | [[Category:Synthetic cannabinoids]] | ||
[[Category: | [[Category:Indoles]] | ||
[[Category:Naphthoylindoles]] | [[Category:Naphthoylindoles]] | ||
Latest revision as of 18:57, 23 March 2025
Synthetic cannabinoid
JWH-015 is a synthetic cannabinoid that acts as a selective agonist for the cannabinoid receptors. It is part of the naphthoylindole family of compounds and is known for its potential therapeutic applications as well as its use in scientific research.
Chemical Properties[edit]
JWH-015 is chemically classified as a naphthoylindole, with the full chemical name (2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone. It has a molecular formula of C24H23NO and a molecular weight of 341.45 g/mol. The compound is characterized by its indole core structure, which is common among many synthetic cannabinoids.
Pharmacology[edit]
JWH-015 acts as a selective agonist for the CB2 receptor, with a moderate affinity for the CB1 receptor. This selectivity makes it of interest for research into the endocannabinoid system and its potential therapeutic applications, particularly in the modulation of immune responses and inflammation.
Mechanism of Action[edit]
The primary action of JWH-015 is through its interaction with the CB2 receptor, which is predominantly expressed in the immune system. Activation of this receptor by JWH-015 can lead to anti-inflammatory effects and modulation of immune cell activity. The compound's lower affinity for the CB1 receptor, which is primarily found in the central nervous system, results in fewer psychoactive effects compared to other cannabinoids.
Potential Applications[edit]
Research into JWH-015 has explored its potential use in treating conditions such as chronic pain, inflammation, and autoimmune diseases. Its selective action on the CB2 receptor makes it a candidate for therapies that aim to minimize psychoactive side effects while providing therapeutic benefits.
Legal Status[edit]
The legal status of JWH-015 varies by country. In some jurisdictions, it is classified as a controlled substance due to its structural similarity to other synthetic cannabinoids that have been associated with recreational use and potential abuse.
Safety and Toxicology[edit]
As with many synthetic cannabinoids, the safety profile of JWH-015 is not fully understood. Studies have indicated that it may have a lower risk of psychoactive effects compared to other cannabinoids, but its long-term effects and potential toxicity remain areas of active research.
